Acquisition by Heather Kidwell of 24190 shares of ZimVie subject to Rule 16b-3
| ZIMV Stock | USD 14.17 0.35 2.41% |
Slightly above 61% of ZimVie's investor base is looking to short. The analysis of overall sentiment of trading ZimVie Inc stock suggests that many investors are alarmed at this time. ZimVie's investing sentiment can be driven by a variety of factors including economic data, ZimVie's earnings reports, geopolitical events, and overall market trends.
ZimVie |
Filed transaction by ZimVie Inc Officer: See Remarks Below.. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
ZimVie Fundamental Analysis
We analyze ZimVie's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ZimVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ZimVie based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
ZimVie is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
ZimVie Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ZimVie stock to make a market-neutral strategy. Peer analysis of ZimVie could also be used in its relative valuation, which is a method of valuing ZimVie by comparing valuation metrics with similar companies.
Peers
ZimVie Related Equities
| APYX | Apyx Medical | 4.11 | ||||
| SNN | Smith Nephew | 1.38 | ||||
| CNMD | CONMED | 0.67 | ||||
| STE | STERIS Plc | 0.64 | ||||
| AORT | Artivion | 0.48 | ||||
| BSX | Boston Scientific | 0.32 | ||||
| SYK | Stryker | 0.16 | ||||
| CVRX | CVRx | 0.24 | ||||
| OFIX | Orthofix Medical | 0.32 | ||||
| SRDX | SurModics | 0.84 | ||||
| SIBN | Si Bone | 1.05 | ||||
| LUNG | Pulmonx Corp | 2.40 | ||||
| SGHT | Sight Sciences | 2.62 | ||||
| KIDS | Orthopediatrics Corp | 2.82 | ||||
| NPCE | Neuropace | 3.40 | ||||
| INGN | Inogen | 4.63 |
Additional Tools for ZimVie Stock Analysis
When running ZimVie's price analysis, check to measure ZimVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ZimVie is operating at the current time. Most of ZimVie's value examination focuses on studying past and present price action to predict the probability of ZimVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ZimVie's price. Additionally, you may evaluate how the addition of ZimVie to your portfolios can decrease your overall portfolio volatility.